Volume | 234,381 |
|
|||||
News | - | ||||||
Day High | 137.755 | Low High |
|||||
Day Low | 131.23 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Masimo Corporation | MASI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
136.25 | 131.23 | 137.755 | 135.92 | 136.95 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,014 | 234,381 | $ 136.21 | $ 31,925,308 | - | 75.22 - 196.83 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:11:37 | formt | 2,194 | $ 135.92 | USD |
Masimo (MASI) Options Flow Summary
Masimo Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.19B | 52.91M | - | 2.05B | 81.5M | 1.54 | 88.19 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Masimo News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MASI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 138.19 | 138.99 | 131.23 | 135.74 | 266,143 | -2.27 | -1.64% |
1 Month | 141.52 | 147.89 | 131.23 | 140.95 | 414,261 | -5.60 | -3.96% |
3 Months | 130.68 | 153.93 | 120.85 | 134.97 | 525,060 | 5.24 | 4.01% |
6 Months | 79.33 | 153.93 | 75.36 | 113.16 | 712,823 | 56.59 | 71.33% |
1 Year | 196.03 | 196.83 | 75.22 | 116.99 | 773,551 | -60.11 | -30.66% |
3 Years | 247.35 | 305.21 | 75.22 | 147.72 | 636,478 | -111.43 | -45.05% |
5 Years | 127.53 | 305.21 | 75.22 | 163.19 | 535,882 | 8.39 | 6.58% |
Masimo Description
Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (67% of 2020 sales), followed by Europe, the Middle East, and Africa (21%), Asia and Australia (9%), and North and South America excluding the U.S. (3%). |